Symetron Biosciences Revenue

Biotechnology Research • Miami, Florida, United States • 1-10 Employees

Symetron Biosciences revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at Symetron Biosciences

Benjamin Medvin

Founder

Company overview

Headquarters	Miami, Florida, United States
NAICS	541714
Keywords	Pharmaceutical Sales, Market Intelligence, Strategic Partnerships, Fundraising, Marketing Strategy, Business Development, Oncology, Microbiology, Synthetic Biology, Genomics, Molecular Biology, Immunology, Virology, Drug Discovery & Development, Neurobiology, Product Launch Strategy, Next-Generation Sequencing (Ngs), Contract Research Organization (Cro) Services, Licensing & Commercialization Strategy, Research Use Only (Ruo) Services
Founded	2025
Employees	1-10

About Symetron Biosciences

Partnering with innovators to accelerate transformative biotech and pharmaceutical solutions from discovery to market. We empower researchers, developers, and manufacturers to commercialize cutting-edge health technologies by bridging science, strategy, and execution with global partners across academia, industry, and government. From Bench to Bedside. From Insight to Impact. 📧 Contact: symetronbiosciences@proton.me

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Employees by Department

Symetron Biosciences has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

Symetron Biosciences has never raised funding before.

Frequently asked questions

Symetron Biosciences is located in Miami, Florida, US.

Symetron Biosciences generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

Symetron Biosciences has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Symetron Biosciences was founded in 2025, making it 1 years old. The company has established itself as a significant player in its industry over this time.

Symetron Biosciences has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at Symetron Biosciences

Benjamin Medvin

Founder

4.8

40,000 users